At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Epilepsy Phenome/Genome Project (EPGP)

Clinical Trial Title: 
Epilepsy phenome/genome project (EPGP)
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Michael C. Smith, MD
Clinical Trial Protocol Description: 

EPGP is a team of 13 clinical centers across the United States working in collaboration with the National Institutes of Health and various organizations devoted to the care of patients with epilepsy. The study will include 1,500 pairs of siblings with generalized or localization-related epilepsy, 1,500 controls who do not have epilepsy, and 750 patients with rare epilepsies along with their parents. Everyone who volunteers for EPGP will be asked to give a sample of their DNA via a blood draw and answer some questions asked by a study nurse or physician.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are between the ages of 4 weeks and 60 years old.
  • Have been diagnosed with IGE or LRE and have a sibling with epilepsy.
  • Have been diagnosed with IS, LGS, PVH or PMG and both of your parents can volunteer.

You will be excluded from the study if any of the following criteria apply to you:

  • Have epilepsy as a result of head injuries, stroke, brain infection other known causes of seizures or epilepsy.

This is a partial list of eligibility requirements. 

Clinical Trial Area: 
Contact Phone: 
(312) 563-2689
Contact Name: 
Laura Przepiorka, RN